From what I see on the chart of AXP, there's a neutral short-term trend playing out within a broader downtrend that's developed over the past quarter. Shares have fallen about -17% year-to-date from a 52-week high near $387, and now they're trading around $305-$306 in a consolidation phase over the last 30 days, posting a modest 1.7% gain. The price action is forming higher lows in what looks like an impulsive structure, but the inability to reclaim longer-term moving averages points to ongoing bearish pressure. One thing that stands out is the key upward-sloping weekly trendline from October 2023, which has acted as support on three occasions now—the current test near $300 is something I'm watching closely for potential bounces, as we've seen before.
Pivot analysis puts the classic pivot right at $302, which lines up neatly with the recent consolidation range. Immediate support is at S1 $291.48, with deeper levels down at S2 $280 and S3 $259. On the resistance side, it starts at R1 $312.97, then R2 $323.46, and R3 $345. These align well with the zones traders are focused on: $300 as that critical trendline support, and $310-$315 as a potential breakout area. In my view, a sustained move above $313 could open up targets around $340, while a break below $291 might quicken the pace toward those lower supports.
Momentum indicators are holding a balanced stance right now, but there are hints of bullish divergence emerging. The daily RSI (14) sits at 48.17, firmly neutral and steering clear of overbought or oversold territory. On the weekly chart, RSI is near 38—edging toward oversold—while forming higher lows relative to price, which is a classic bullish signal. The MACD (12,26) at -5.89 is flashing a buy signal, bolstered by divergences on both daily and weekly timeframes where momentum isn't keeping pace with the price declines. Stochastic %K (14,3,3) at 70.54 remains neutral, and CCI (20) at 80.93 indicates there's still room to the upside before hitting overbought levels.
The shorter-term moving averages are leaning bullish: EMA(10) at $300.93 (buy), SMA(20) at $300.14 (buy), and VWMA(20) at $300.04 (buy). That said, price is still trading below the longer-term averages—SMA(50) at $324.19 (sell), SMA(100) at $346.01 (sell), and SMA(200) at $335.39 (sell). This bearish setup across the key 50-, 100-, and 200-day MAs confirms the intermediate downtrend. I also checked this using Tickeron’s AI Screener to see how AXP stacks up against peers, and a crossover above the 50-day SMA would be a pivotal signal for any reversal.
Volume lately has been running below average, around 780K shares compared to the typical 3.8M, which fits with the subdued action during this consolidation. I've noticed demand picking up on those trendline tests, and volume spikes would be key to watch on any breakouts. With a beta of 1.30, AXP shows higher volatility than the broader market, which is typical for financial sector names.
In my own research, I turn to Tickeron’s AI Daily Buy/Sell Signals to analyze stocks like AXP. This tool uses artificial intelligence to dig through massive amounts of market data, technical indicators, and price patterns, delivering actionable buy or sell signals. It pulls from trend recognition, historical pattern matching, and momentum analysis to help spot entry and exit points, confirm trends, and support trading decisions—especially useful in volatile stretches. I find it reliable for validating chart setups and sharpening timing. If you're looking for real-time insights tied to the current market, checking out the AI Daily Buy/Sell Signals is part of my routine.
Overall, I'm keeping an eye on whether AXP holds above that $300 trendline support for any bullish continuation—a weekly close above $310-$315 could push toward $340-$360, and maybe even extensions to $380. On the flip side, a drop below $291 might test those deeper supports at $280. Key things to monitor include sustained bullish divergence in RSI, MACD crossovers, and volume pickup on moves toward R1 at $313. The short-term MAs could offer dynamic support, but reclaiming the 50-day SMA at $324 is crucial for any real trend shift.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
AXP moved above its 50-day moving average on April 13, 2026 date and that indicates a change from a downward trend to an upward trend. In of 33 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on March 31, 2026. You may want to consider a long position or call options on AXP as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for AXP just turned positive on March 19, 2026. Looking at past instances where AXP's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AXP advanced for three days, in of 333 cases, the price rose further within the following month. The odds of a continued upward trend are .
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The 50-day moving average for AXP moved below the 200-day moving average on March 24, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AXP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
AXP broke above its upper Bollinger Band on April 13, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for AXP entered a downward trend on March 31, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AXP’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.698) is normal, around the industry mean (12.651). P/E Ratio (21.259) is within average values for comparable stocks, (17.647). Projected Growth (PEG Ratio) (1.681) is also within normal values, averaging (1.276). Dividend Yield (0.010) settles around the average of (0.273) among similar stocks. P/S Ratio (3.151) is also within normal values, averaging (135.731).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a financial conglomerate
Industry SavingsBanks